Delayed radiation, myelopathy: Serial MR-imaging and pathology

Clinical Neurology and Neurosurgery

Volumn 98, Issue 2, 1996, Pages 197-201

  Koehler, P J ^a   Verbiest, H ^b   Jager, J ^c   Vecht, Ch J ^b  

^a De Wever Hospital ^*  (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAASTRO CLINIC   (Netherlands)

Author keywords

Adverse effect; MR scan; Myelopathy; Radiotherapy

Indexed keywords

COUMARIN DERIVATIVE; LIPID;

ADULT; AGED; ARTICLE; ASTROCYTE; AUTOPSY; BLOOD VESSEL WALL; CALCIFICATION; CASE REPORT; CERVICAL LYMPH NODE; DIABETES MELLITUS; FEMALE; HUMAN; HYALINE DEGENERATION; LYMPH NODE METASTASIS; MACROPHAGE; NECROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; QUADRIPLEGIA; RADIATION DOSE; RADIATION INJURY; RISK FACTOR; SPINAL CORD DISEASE; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; WHITE MATTER;

EID: 0030152917     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-8467(96)00017-0     Document Type: Article

References (15)

1. [1] Schultheiss, T.E., Higgins, E.M. and El-Mahdi, A.M. (1984) The latent period in clinical radiation myelopathy. Int. J. Radiat. Oncol. Biol. Phys., 10: 1109-1115.
2. [2] Reagan, T.J., Thomas, J.E. and Colby Jr., M.Y. (1968) Chronic progressive radiation myelopathy. JAMA, 203: 106-110.
3. [3] Rubin, P., Whitaker, J.N., Ceckler, T.L. et al. (1988) Myelin basic protein and magnetic resonance imaging for diagnosing radiation myelopathy. Int. J. Radiot. Oncol. Phys., 15: 1371-1381.
4. [4] Baddeley, H., Bekiaridis, S., Dische, S. and Saunders, M.I. (1991) Magnetic resonance imaging in the diagnosis of radiation myelitis. Br. J. Radiol., 64 (Suppl.): 45.
5. [5] Toffol, B. de, Cotty, Ph., Calais, G., Ramos, F., Gaymard, B., Laffont, J. and Autret, A. (1989) Myilopathie postradiothirapique cervicale chronique apport de l'IRM. J. Neuroradiol., 16: 251-253.
6. [6] Wang, P.-Y., Shen, W.-C. and Jan, J.-S. (1992) MR imaging in radiation myelopathy. AJNR, 13: 1049-1055.
7. [7] Schultheiss, T.E. and Stephens, L.C. (1992) Radiation myelopathy. AJNR, 13: 1056-1058.
8. [8] Worthington, S. (1979) Diffuse cord enlargement in radiation myelopathy. Clin. Radiol., 30: 117-119.
9. [9] Schultheiss, T.E., Stephens, L.C. and Maor, M.H. (1988) Analysis of the histopathology of radiation myelopathy. Int. J. Radiat. Oncol. Biol. Phys., 27: 27-32.
10. [10] Leibel, S.A. and Sheline, G.E. (1991) Tolerance of the brain and spinal cord to conventional irradiation. In: P.H. Gutin, S.A. Leibel and G.E. Seline (Eds.), Radiation Injury to the Nervous System, Raven Press, New York.
11. [11] Schultheiss, T.E. and Stephens, L.C. (1992) Permanent radiation myelopathy. Br. J. Radiol., 65: 737-753.
12. [12] Wong, C.S., Van Dyk, J. and Simpson, W.J. (1991) Myelopathy following hyperfractionated accelerated radiotherapy for anaplasic thyroid carcinoma. Radiother. Oncol., 20: 3-9.
13. [13] Vecht, Ch.J. and Van der Kogel, A.J. (1992) Radiation myelopathy. In: H.L. Frankel (Ed.), Handbook of Clinical Neurology, Vol. 17-(61): Spinal cord trauma (Ch. 11), Elsevier, Amsterdam.
14. [14] Glantz, M.J., Burger, P.C., Friedman, A.H., Radtke, R.A., Massey, E.W. and Schold Jr., S.C. (1994) Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology, 44: 2020-2027.
15. [15] Schultheiss, T.E., Stephens, L.C. and Peters, L.J. (1986) Survival in radiation myelopathy. Int. J. Radiat. Biol. Biol. Phys. 12: 1765-1769.